CEPI's nine candidate vaccines against COVID-19
This composite image shows research and development of the nine vaccines against COVID-19 that CEPI has funded to date (from upper left hand corner: Clover Pharmaceuticals, CureVac, INOVIO, Moderna, Novavax, Themis, University of Hong Kong, University of Oxford, University of Queensland.)
Format
JPEG
Source
ADX Labs, Inc.